Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Johnson & Johnson    JNJ

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

General Motors, Walmart, Pepsico and FX Networks also suspend Google ads

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/26/2017 | 12:32pm CEST

Another wave of marketers has suspended advertising on YouTube or in some cases other Google properties in what’s shaping up as an unprecedented revolt against the world’s largest digital media player over ads placed with objectionable content. General Motors, Walmart, Pepsico and FX Networks on Friday joined brand marketers that include Johnson & Johnson, Verizon […]

(c) 2017 MediaQuest Corp. All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on JOHNSON & JOHNSON
12:32p General Motors, Walmart, Pepsico and FX Networks also suspend Google ads
10:54a US featured innovative medical technologies at Riyadh event
03/25 AT&T, Verizon halt Google ads over extremist videos
03/24 JOHNSON & JOHNSON : Innovation launches Singapore QuickFire Challenge Competitio..
03/24 AT&T and Johnson & Johnson Pull Ads From YouTube
03/24 OPPORTUNISM KNOCKS : Marketers and media take on Google
03/24 JOHNSON & JOHNSON : EPREX Marketing Authorisation Extended to Include Treatment ..
03/24 YouTube's bid to grab TV dollars imperiled by advertiser revolt
03/24 HOLOGIC : Global in-Vitro Diagnostics (IVD) Market-Danaher, Hologic, Alere, BD, ..
03/24 JOHNSON & JOHNSON : Global First Aid Kit Market-Honeywell, Wah Lee, Yunnan Baiya..
More news
Sector news : Pharmaceuticals - NEC
03/24 NOVO NORDISK A/S : EMA panel backs Novo Nordisk's haemophilia B drug
03/23DJPRESS RELEASE : FDA Grants Approval for -3-
03/23DJPRESS RELEASE : FDA Grants Approval for -2-
03/23DJPRESS RELEASE : FDA Grants Approval for BAVENCIO(R) (avelumab), the First Immuno..
03/23 TEVA PHARMACEUTICAL INDUSTRIES : Pharm says media reports of up to 6,000 layoffs..
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
03/24 The View From The Top
03/24 RETIREES : How To Protect The Principal Of Your Dividend Portfolio
03/24 European advisory committee backs J & J's Elmiron for bladder pain syndrome
03/24 WALL STREET BREAKFAST : Art Of The Healthcare Deal
03/24 YouTube ad exodus continues
Advertisement
Financials ($)
Sales 2017 74 632 M
EBIT 2017 23 011 M
Net income 2017 17 928 M
Finance 2017 21 362 M
Yield 2017 2,67%
P/E ratio 2017 19,01
P/E ratio 2018 17,74
EV / Sales 2017 4,27x
EV / Sales 2018 4,01x
Capitalization 340 163 M
More Financials
Chart JOHNSON & JOHNSON
Duration : Period :
Johnson & Johnson Technical Analysis Chart | JNJ | US4781601046 | 4-Traders
Full-screen chart
Technical analysis trends JOHNSON & JOHNSON
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 126 $
Spread / Average Target 0,65%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Alex Gorsky Chairman & Chief Executive Officer
Dominic J. Caruso Chief Financial Officer & Vice President
Paulus Stoffels Chief Scientific Officer & Executive VP
Charles O. Prince Independent Director
William David Perez Independent Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
JOHNSON & JOHNSON8.91%340 163
ROCHE HOLDING LTD.8.73%219 545
PFIZER INC.4.68%202 474
NOVARTIS AG-0.94%195 096
MERCK & CO., INC.7.32%173 465
SANOFI7.76%115 582
More Results